How Autophagy Affects Ferroptosis in Diabetic Liver Injury
Author Information
Author(s): Wu Liangxiu, Lai Weicheng, Li Lanlan, Yang Sen, Li Fengjuan, Yang Chen, Gong Xiaobing, Wu Liangyan
Primary Institution: The First Affiliated Hospital of Jinan University
Hypothesis
This study investigates the role of autophagy in regulating ferroptosis through the degradation of ACSL4 in diabetic hepatocytes.
Conclusion
The study found that autophagy regulates ferroptosis by modulating ACSL4 degradation, which contributes to diabetic liver injury.
Supporting Evidence
- Ferroptosis was observed in diabetic hepatocytes and palmitic acid-treated LO2 cells.
- ACSL4 levels were significantly higher in diabetic rats compared to controls.
- Autophagy was inhibited in the liver of STZ-induced diabetic rats.
- Ferroptosis inhibitor Fer-1 improved cell viability in PA-treated LO2 cells.
- ACSL4 was predominantly degraded via the autophagy-lysosomal pathway.
- 3-Methyladenine, an autophagy inhibitor, increased ACSL4 levels and promoted ferroptosis.
- Rapamycin, an autophagy inducer, decreased ACSL4 expression in LO2 cells.
Takeaway
In diabetes, a process called ferroptosis can harm the liver, and a helper process called autophagy can control this harm by breaking down a protein called ACSL4.
Methodology
The study used streptozotocin-induced diabetic rats and palmitic acid-treated LO2 cells to assess ferroptosis and autophagy.
Limitations
The study does not fully elucidate the molecular mechanisms by which palmitic acid regulates ACSL4 transcription.
Participant Demographics
Healthy male Sprague-Dawley rats were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website